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For decades scientists have tried to measure bone blood flow but this is
fraught with difficulty for several reasons. Any attempt to penetrate the
bone cortex will invariably disrupt blood flow measurement; as opposed to
say the heart or the brain, most bones are supplied by many small arteries,
and blood flow often varies tremendously from one bone area to another.
Traditionally microspheres or radionuclide techniques have been used to
measure blood flow. Nowadays, however, reliable assessment of bone
vascularity is possible with dynamic contrast enhanced MRI imaging and
PET imaging techniques. Dynamic contrast-enhanced MR imaging is the most
widely applied technique used to measure bone perfusion. The terms blood
flow and tissue perfusion represent different physiological processes. Bone
blood flow is flow within blood vessels while perfusion is much more
encompassing and biologically relevant term reflecting not just vascular
flow but also capillary capacitance, capillary permeability and interstitial
diffusion. Dynamic contrast-enhanced MRI imaging measures bone perfusion
rather than bone blood flow. Good tissue perfusion is essential to fracture
healing including healing of trabecular microfracture. The most metaboli-
cally active areas of bone are those which are best perfused whilst
trabecular rich areas of bone typically represent areas of good perfusion.
The principal factor driving bone marrow perfusion seems to the marrow red
cell mass. This is understandable since red marrow is many times more
metabolically active than fatty marrow. Marrow perfusion decreases with
increasing age and is especially decreased in osteoporotic bone in line with
an increase in marrow fat content. It is understandable that are quite
osteoporotic fractures slow to heal.
In the future, more advanced MR imaging techniques (such as blood
oxygenation level dependent [BOLD] imaging or intravoxal incoherent
motion [IVIM]) may well allow assessment of bone perfusion without having
to administer to intravenous contrast agent.
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HR-QCT ASSESSMENT OF BONE BEYOND BONE MINERAL DENSITY
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Amongst techniques providing more comprehensive information on bone
fragility compared to Dual X-ray Absorptiometry (DXA) Quantitative
Computed Tomography (QCT) is the strongest and most versatile approach.
It has potential for assessment of bone microstructure and bone material
properties, two factors considered most relevant as predictors of bone
fragility beyond bone mineral density (BMD). In order to exploit its potential
for accurate 3-D assessment of these factors, accurate delineation of bone
tissue from marrow, fat or muscle tissue is essential. High Resolution QCT
(HR-QCT) approaches have been developed over the past years with
substantial progress in the pursuit of these goals.
In this contribution I will focus on HR-QCT of the spine and the proximal
femur, the two most relevant sites for assessment of bone fragility. By using
higher collimation (<0.5 mm), higher photon flux (radiation exposure 2e3
mSv) and high resolution reconstruction kernels one can reconstruct images
with in-plane resolution of 150e200 mm. Special software (e.g. Structural
Insight at our institution) permits refined assessment of the trabecular
network, e.g. by estimation of apparent trabecular separation and bone
volume fraction. Spatial deconvolution techniques generate estimates of
cortical thickness and tissue mineral density (TMD) with strong improvement
in accuracy. Moreover, the status of marrow fat can be estimated providing a
basis for correction of BMD and TMD.
Interestingly, the software also improves structural assessment on regular
QCT images, documenting substantial improvement over standard QCT
results. The improved spatial depiction also provides a superior basis for
finite element modeling. I will present validation results and document the
merits of HR-QCT in the assessment of treatment effects, e.g. by differen-
tiating bone anabolic from anti-resorptive effects.
In conclusion, HR-QCT has potential for substantially improved assessment
of bone fragility and treatment effects.
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Alan Brett, PhD
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Central DXA of the lumbar spine and proximal femur is the preferred method
for bone mineral density (BMD) testing. Despite the fracture risk statistics,
osteoporosis testing with dual energy X-ray absorptiometry (DXA) remains
underused. However, BMD can also be assessed with other radiologic imaging
tools, such as quantitative computed tomography (QCT) that may be
available when access to DXA is restricted.
For patients undergoing screening CT colonography (CTC), a potential
opportunity exists for concurrent BMD screening by QCT without the need
for any additional imaging, radiation exposure, or patient time. In addition,
there are a number of indications for CT imaging for which there is a large
overlap between the need for a CT scan and a patient having risk factors for
osteoporosis. Use may also be made of these CT images for BMD measure-
ment by QCT. Such dual-use of CT images could increase screening rates or,
alternatively, preclude the need for DXA screening in some individuals.
Previous studies combining standard CT imaging and QCT have generally
focused on BMD measurement at the lumbar spine. QCT provides a volumetric
BMD measure of the trabecular vertebral bone in isolation. This can have an
advantage of superior sensitivity due to the higher turnover rate of trabecular
bone, but QCT T-scores are somewhat lower than DXA T-scores for the same
age and the established WHO classification of osteoporosis by DXA T-score is
not appropriate. In contrast, at the proximal femur, QCT 3D data may be used
to derive a projectional 2D image of the proximal femur and this imagemay be
analyzed using standard DXA ROIs to determine DXA-equivalent “CTXA” aBMD
values in g/cm2. Using this method, the WHO T-score classifications may be
applied and the aBMD measures may be included in FRAX calculations.
Theworkflowassociatedwith such dual-use of CTscansmaybe improved by the
use of phantomless or “asynchronous” calibration methods, so that the BMD
measurement does not need to be planned in advance of the CT scan. In
addition, using such methods, it is possible to make use of archived CT scans
retrospectively. Finally, the use of IV contrast-enhanced CT images for QCT is
usually contraindicated and a measurement bias has been shown at the spine.
However, some recent studies suggest that for measurements made at the hip,
themeasurementdifferencedue tocontrast enhancementmaynotbeclinically
significant, further widening the utility of CT scans for BMD measurement.
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ADVANCED vQCT AND HR-pQCT IN SCIENCE AND CLINICAL TRIALS
Klaus Engelke
Institute of Medical Physics, University of Erlangen, Germany
QCT is increasingly used for the analysis of clinical studies and of
epidemiology data. To date a number of different software options exist
for the analysis of QCT images. As a consequence, a multitude of parameters
related to bone mineral density, bone geometry and related to bone
strength can be obtained in various volumes of interest in the spine and
proximal femur. Many of them are highly correlated and appropriate analysis
strategies will be discussed. In addition a number of different algorithms
such as global or local adaptive thresholds using different criteria to segment
the cortex are in use to quantify parameters such as cortical BMD, BMC or
thickness. Strengths and weaknesses of the different approaches will be
discussed by comparing effects on accuracy errors of one-time measure-
ments and on accuracy errors of changes during longitudinal measurements.
In contrast to QCT, hr-pQCT measurements of the radius and tibia are more
standardized as only the XtremeCT scanner is available for hr-pQCT
measurements in humans. But also for this scanner different algorithms to
assess the cortex exist and a newer version, which allows for faster scan
times and slightly higher spatial resolution has been introduced recently.
The lecture will review recent use of QCT using whole body CT scanners and
of hr-pQCT to predict or discriminate hip fracture and to monitor age related
changes or treatment efficacy in recent clinical trials in osteoporosis. It will
include a brief introduction to advanced QCT methodology. Learning
objectives are to understand what is measured by QCT, what are the
advantages of QCT and hr-pQCT (in particular compared to DXA) and what
potential pitfalls exist in the interpretation of QCT and hr-pQCT parameters.
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